Itamar Medical, a medical technology company based in Israel and with US headquarters in Atlanta, focuses on developing and commercializing non-invasive medical devices to help diagnose respiratory sleep disorders. Its key product, WatchPAT, is available in major markets including the US, Japan, and Europe. The company's digital healthcare platform facilitates sleep apnea management and optimization of patient care, with a focus on sleep, cardiology, and direct-to-consumer markets. Itamar Medical aims to reduce healthcare system costs and provide physicians with comprehensive sleep apnea management solutions. The company is publicly traded on the Nasdaq and the Tel Aviv Stock Exchanges.